Windward Bio Group AG
WWB- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0002145089
In the last 90 days, Windward Bio Group AG insiders filed 2 open-market purchases and 0 sales; no institution reported holding it in 13F filings for Q3 2026; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Windward Bio Group AG insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 2 filings
- 2 insiders, $49.8M in total
- Open-market sells
- 0 filings
- Insiders trading
- 2
- Net value
- +$49.8M
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Windward Bio Group AG, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Bonita David P | Director, 10% Owner | 7,097,483Indirect | Nov 18, 2026 | 2 |
| OrbiMed Advisors LLC | Director, 10% Owner | 7,097,483Indirect | Nov 18, 2026 | 1 |
| OrbiMed Capital GP IX LLC | Director, 10% Owner | 7,097,483Indirect | Nov 18, 2026 | 1 |
| Stampacchia Otello | Director | 2,669,260Indirect | Nov 18, 2026 | 2 |
| Mufti Iqbal Rasool | Director | – | Nov 16, 2026 | 1 |
| D'Augusta Claudia | Chief Financial Officer | – | Nov 16, 2026 | 1 |
| Khwaja Omar | Chief Medical Officer | – | Nov 16, 2026 | 1 |
| Santarelli Luca | Chief Executive Officer | – | Nov 16, 2026 | 1 |
| Kapadia Sandip | Director | 100,000 | Nov 16, 2026 | 1 |
| Harris Kevin Andrew | Chief Operating Officer | 960,966 | Nov 16, 2026 | 1 |
| Applebaum Scott | Chief Legal & Corp Dev Officer | 960,966 | Nov 16, 2026 | 1 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 18, 2026 (view filing)5:12 PM ET | Nov 16 | 2 days | Bonita David PDirector, 10% Owner | PPurchase | +1.18M | $17.00 | +$20.0M | +221.3%1.71M after | Duplicate filing |
| Nov 18, 2026 (view filing)5:08 PM ET | Nov 16 | 2 days | OrbiMed Advisors LLC and 1 otherDirector, 10% Owner | PPurchase | +1.18M | $17.00 | +$20.0M | +221.3%1.71M after | |
| Nov 18, 2026 (view filing)4:30 PM ET | Nov 16 | 2 days | Stampacchia OtelloDirector | PPurchase | +1.75M | $17.00 | +$29.8M | New position875.0K after | 2 lots |